tradingkey.logo
tradingkey.logo
Buscar

Utah Medical Products Inc

UTMD
Añadir a la lista de seguimiento
72.780USD
+2.150+3.04%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
231.73MCap. mercado
21.52P/E TTM

Más Datos de Utah Medical Products Inc Compañía

Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.

Información de Utah Medical Products Inc

Símbolo de cotizaciónUTMD
Nombre de la empresaUtah Medical Products Inc
Fecha de salida a bolsaDec 01, 1982
Director ejecutivoCornwell (Kevin L)
Número de empleados155
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 01
Dirección7043 S 300 West
CiudadMIDVALE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal84070
Teléfono18015215301
Sitio Webhttp://www.utahmed.com
Símbolo de cotizaciónUTMD
Fecha de salida a bolsaDec 01, 1982
Director ejecutivoCornwell (Kevin L)

Ejecutivos de Utah Medical Products Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.14K
-0.47%
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Mr. Ernst G. Hoyer
Mr. Ernst G. Hoyer
Lead Independent Director
Lead Independent Director
5.00K
--
Ms. Carrie Leigh
Ms. Carrie Leigh
Independent Director
Independent Director
51.00
--
Mr. Brian L. Koopman
Mr. Brian L. Koopman
Principal Financial Officer
Principal Financial Officer
--
--
Mr. Kevin Timken
Mr. Kevin Timken
Director
Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kevin L. Cornwell
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer, Secretary
Chairman of the Board, President, Chief Executive Officer, Secretary
188.47K
--
Mr. Paul O. Richins
Mr. Paul O. Richins
Independent Director
Independent Director
21.14K
-0.47%
Dr. James H. Beeson, M.D., Ph.D.
Dr. James H. Beeson, M.D., Ph.D.
Independent Director
Independent Director
13.13K
--
Mr. Ernst G. Hoyer
Mr. Ernst G. Hoyer
Lead Independent Director
Lead Independent Director
5.00K
--
Ms. Carrie Leigh
Ms. Carrie Leigh
Independent Director
Independent Director
51.00
--
Mr. Brian L. Koopman
Mr. Brian L. Koopman
Principal Financial Officer
Principal Financial Officer
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Utah Medical Products Inc?

Los cinco principales accionistas de Utah Medical Products Inc son: Mr. Kevin L. Cornwell

¿Cuántas instituciones poseen acciones de Utah Medical Products Inc (UTMD)?

A fecha de 2026Q1, 253 instituciones poseen acciones de Utah Medical Products Inc, con un valor de mercado combinado de aproximadamente 2.44M, lo que representa el 76.75% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -74096.00.

¿Cuál es la mayor fuente de ganancias de Utah Medical Products Inc?

El 2026Q1, el segmento empresarial Gynecology/Electrosurgery/Urology generó la ganancia más alta para Utah Medical Products Inc, ascendiendo a 19.72M y representando el 51.19% de la ganancia total.